Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate whether regular use of eflornithine 11.5% cream in treating women with facial hair will induce skin damage (atrophy) on the face and/or forearms


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00152048
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 4
Start date November 30, 2004
Completion date October 31, 2005

See also
  Status Clinical Trial Phase
Completed NCT02103608 - Clinical Evaluation of Silk'n Glide for Face N/A
Not yet recruiting NCT00495443 - Enhanced Safety Aesthetic Laser System N/A
Not yet recruiting NCT06003062 - Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
Active, not recruiting NCT00145288 - Prospective Study of Patients With Hirsutism Phase 2/Phase 3
Enrolling by invitation NCT01461694 - Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser Phase 2/Phase 3
Not yet recruiting NCT00441948 - Enhanced Safety Laser Hair Removal System N/A
Completed NCT03673995 - Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS N/A
Recruiting NCT04979377 - Prevalence of Hyperandrogenism in Type 1 Diabetes
Completed NCT02494297 - DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Completed NCT00960310 - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions Phase 1
Completed NCT02793557 - Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth Phase 1/Phase 2
Completed NCT01555190 - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone N/A
Completed NCT01817894 - Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism Phase 4
Completed NCT00143052 - Bone Status and Insulin Resistance in Hirsutism N/A
Recruiting NCT01338519 - Database Study on Patients With PCOS N/A
Recruiting NCT04292587 - Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
Completed NCT00959335 - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions Phase 1
Not yet recruiting NCT00371930 - Photodynamic Therapy for Permanent Hair Removal Phase 1/Phase 2